ViroPharma, Inc. (NASDAQ:VPHM)
A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
mdriver78
(27.26)
Submitted: 2/7/2012 8:48:20 AM :
Start Price:
$30.95
VPHM Score:
+1.23
FDA strikes again!
Recs
Recs
2trpop
(67.66)
Submitted: 1/17/2012 9:18:28 AM :
Start Price:
$29.56
VPHM Score:
+0.26
momentum play
Recs
mergaman1
(66.08)
Submitted: 1/10/2012 7:28:39 PM :
Start Price:
$28.20
VPHM Score:
+4.24
great company
Recs
Recs
yesand
(35.50)
Submitted: 7/29/2011 2:48:48 PM :
Start Price:
$18.07
VPHM Score:
+66.03
Good pharma in pipeline
Recs
jeffrycooks
(71.64)
Submitted: 4/28/2011 10:35:39 PM :
Start Price:
$9.25
VPHM Score:
+224.68
This one is looking good 4/28/11 may consider this on a good pullback. Like chart, statements, etc...
Recs
RazorSphinx
(< 20)
Submitted: 4/28/2011 7:34:29 AM :
Start Price:
$20.56
VPHM Score:
+49.67
Magic Formula
Recs
NicolasDarvas
(< 20)
Submitted: 1/8/2011 9:23:39 PM :
Start Price:
$17.45
VPHM Score:
+69.27
stockmillionare.
Recs
Hotpicks101
(33.46)
Submitted: 1/6/2011 12:27:10 PM :
Start Price:
$17.68
VPHM Score:
-67.50
zz and ultra.
Recs
onzelot
(< 20)
Submitted: 10/27/2010 4:06:23 PM :
Start Price:
$16.72
VPHM Score:
+70.22
Brings their the product to the rest of the world
Recs
andrepaws
(< 20)
Submitted: 9/24/2010 8:14:50 PM :
Start Price:
$15.12
VPHM Score:
+85.47
any companythat can get seniors to pay 5,000 for meds to clear up hospital infection that medicare
will not cover is already a moneymaker!
Recs
seekdelta
(< 20)
Submitted: 8/30/2010 8:44:26 PM :
Start Price:
$12.61
VPHM Score:
+114.68
As per this article: http://seekingalpha.com/article/220613-viropharma-a-tale-of-two-drugs?source=TheMotleyFool
Recs
LuckyShad
(70.56)
Submitted: 8/18/2010 1:38:55 PM :
Start Price:
$13.54
VPHM Score:
+104.15
CAPS=5/88
Recs
MagicDiligence
(85.77)
Submitted: 8/13/2010 9:18:35 AM :
Start Price:
$13.15
VPHM Score:
+108.70
ViroPharma markets two drugs: Vancocin for clostridium difficile infections, and Cinryze for rare hereditary angioedema. The company's investment potential is tied to how fast the latter can replace declining sales from the former.
Read my full CAPS review here:
http://caps.fool.com/Blogs/viropharma-vphm-a-tale-of/433135
Recs
20100626
(< 20)
Submitted: 7/17/2010 12:32:40 PM :
Start Price:
$10.91
VPHM Score:
+155.06
Bravobevo
Recs
Clint35
(68.90)
Submitted: 3/29/2010 10:58:45 PM :
Start Price:
$14.07
VPHM Score:
+103.17
Sales have gone up over the years. Still a small company. 5 stars. P/E 5.55 Price just under $15. Sounds like a good deal.
Recs
cashsage
(29.64)
Submitted: 12/9/2009 12:26:04 PM :
Start Price:
$7.63
VPHM Score:
-278.48
VPHM has a too high valuation compared to its sales potential. It is also loss making.
Recs
bajamar
(< 20)
Submitted: 11/9/2009 3:37:40 AM :
Start Price:
$7.68
VPHM Score:
+274.10
will be trading in 9to10 range in three weeks
Recs
HIGHG33K
(77.54)
Submitted: 10/21/2009 3:59:26 PM :
Start Price:
$9.50
VPHM Score:
+198.07
A undervalued biotech with a target price around $15
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 178 : 1 2 3 4 5 6 7 8 9 Next »